AFLNYSEAccident & Health InsuranceFiscal year ends December 31
AFLAC INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$118.67−1.30 (-1.08%)
Close on Oct 19, 2026
- Market cap
- $60.00B
- P/E (TTM)
- 12.7
- Dividend yield
- 1.96%
AFLAC INC revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aflac Japan | $8.95B | $9.26B | $9.36B | $9.44B | $9.48B | $9.46B | $9.66B | $9.80B | $10.08B | $10.35B | $10.66B | $10.87B | 49.5% | -5.7% |
| Aflac U.S. | $7.00B | $6.96B | $6.90B | $6.85B | $6.80B | $6.76B | $6.74B | $6.71B | $6.68B | $6.66B | $6.62B | $6.61B | 38.8% | +2.9% |
| Corporate and other | $1.20B | $1.24B | $1.28B | $1.29B | $1.17B | $1.08B | $1.01B | $797.00M | $687.00M | $578.00M | $460.00M | $462.00M | 6.6% | +2.3% |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aflac Japan | $3.43B | $3.48B | $3.44B | $3.48B | $3.33B | $3.41B | $3.49B | $3.50B | $3.30B | $3.26B | $3.23B | $3.20B | +2.9% |
| Aflac U.S. | $1.41B | $1.43B | $1.42B | $1.45B | $1.43B | $1.42B | $1.42B | $1.39B | $1.52B | $1.51B | $1.50B | $1.54B | -1.3% |
| Corporate and other | $28.00M | $58.00M | $101.00M | $128.00M | $74.00M | $77.00M | $32.00M | -$283.00M | -$347.00M | -$422.00M | -$425.00M | -$153.00M | -62.2% |
By product or service
By region
From the segment and revenue-disaggregation notes of Aflac's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.